CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 196 enrolled
Drug / intervention
4L PegLyte + 15 mg bisacodyl +1 moredrug
Likely dose
4L PegLyte + 15 mg bisacodylfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02976805
NCT02976805Phase 3Completed
CompareCT.gov

A Multi-centre Endoscopist Blinded Randomized Clinical Trial to Compare Two Bowel Preparations After a Colonoscopy With Inadequate Bowel Preparation

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·interventional·Posted Nov 29, 2016·Updated Feb 21, 2020

In Brief

A Phase 3 clinical trial evaluating 4L PegLyte + 15 mg bisacodyl and 6L PegLyte + 15 mg bisacodyl for Colonoscopy and Bowel Preparation. Completed, enrolled 196 participants across 4 sites.

Detailed Summary

This is a multi-centre randomized clinical trial comparing the efficacy of two different bowel preparation regimens for patients who have already failed a bowel preparation for colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy, Bowel Preparation
CountriesCanada
CollaboratorsAcademic Medical Organization of Southwestern Ontario, Pendopharm, University of Alberta, Université de Montréal, McGill University, University of Western Ontario, Canada

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 29, 2016
Enrollment StartFeb 13, 2017
Primary CompletionFeb 19, 2020
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 9.6 years ago

Interventions

4L PegLyte + 15 mg bisacodyldrug

Randomized

6L PegLyte + 15 mg bisacodyldrug

Randomized